
Figure 1
Potential roles of EPFRs in enhancing viral morbidity and mortality.

Figure 2
The SARS-CoV-2 NTD comprised multiple mutation at 48 and 72h post EPFR exposure. Mutations are highlighted as yellow spheres.

© 2022 Stephania A Cormier, Ayaho Yamamoto, Kirsty R. Short, Luan Vu, William A Suk, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.